Xalkori is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Crizotinib.
| Product ID | 0069-8140_19c4d302-9bf2-4557-8f22-f2c94341fd1a |
| NDC | 0069-8140 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Xalkori |
| Generic Name | Crizotinib |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-08-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202570 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | CRIZOTINIB |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Receptor Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2B6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2011-08-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202570 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-08-26 |
| Ingredient | Strength |
|---|---|
| CRIZOTINIB | 250 mg/1 |
| SPL SET ID: | 2a51b0de-47d6-455e-a94c-d2c737b04ff7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-8140 | Xalkori | CRIZOTINIB |
| 0069-8141 | Xalkori | CRIZOTINIB |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XALKORI 85069606 3967863 Live/Registered |
Pfizer Inc. 2010-06-23 |